메뉴 건너뛰기




Volumn 125, Issue 6, 2004, Pages 2140-2145

Treatment costs of community-acquired pneumonia in an employed population

Author keywords

Antibiotic resistance; Community acquired pneumonia; Economic impact

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COST BENEFIT ANALYSIS; DATA BASE; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

EID: 2942722305     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.6.2140     Document Type: Article
Times cited : (113)

References (20)
  • 1
    • 0031693610 scopus 로고    scopus 로고
    • The cost of treating community-acquired pneumonia
    • Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20:820-837
    • (1998) Clin Ther , vol.20 , pp. 820-837
    • Niederman, M.S.1    McCombs, J.S.2    Unger, A.N.3
  • 2
    • 0034959819 scopus 로고    scopus 로고
    • Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention
    • Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. 1730-1754
    • Niederman, M.S.1    Mandell, L.A.2    Anzueto, A.3
  • 3
    • 0034458012 scopus 로고    scopus 로고
    • Practice guidelines for the management of community-acquired pneumonia
    • Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia. Clin Infect Dis 2000; 31:347-382
    • (2000) Clin Infect Dis , vol.31 , pp. 347-382
    • Bartlett, J.G.1    Dowell, S.F.2    Mandell, L.A.3
  • 4
    • 0037086365 scopus 로고    scopus 로고
    • Hospitalized community-acquired pneumonia in the elderly
    • Kaplan V, Angus DC, Griffin MF, et al. Hospitalized community-acquired pneumonia in the elderly. Am J Respir Crit Care Med 2002; 165:766-772
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 766-772
    • Kaplan, V.1    Angus, D.C.2    Griffin, M.F.3
  • 5
    • 0032110852 scopus 로고    scopus 로고
    • Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia
    • Whittle J, Lin CJ, Lave JR, et al. Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia. Med Care 1998; 36:977-987
    • (1998) Med Care , vol.36 , pp. 977-987
    • Whittle, J.1    Lin, C.J.2    Lave, J.R.3
  • 6
    • 0030031642 scopus 로고
    • Prognosis and outcomes of patients with community-acquired pneumonia
    • Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 1995; 274:134-141
    • (1995) JAMA , vol.274 , pp. 134-141
    • Fine, M.J.1    Smith, M.A.2    Carson, C.A.3
  • 7
    • 0030814756 scopus 로고    scopus 로고
    • Incidence of community-acquired pneumonia requiring hospitalization
    • Marston BJ, Plouffe JF, File TM, et al. Incidence of community-acquired pneumonia requiring hospitalization. Arch Intern Med 1997; 157:1709-1718
    • (1997) Arch Intern Med , vol.157 , pp. 1709-1718
    • Marston, B.J.1    Plouffe, J.F.2    File, T.M.3
  • 8
    • 0033805103 scopus 로고    scopus 로고
    • Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia
    • Fine MJ, Pratt HM, Obrosky DS, et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. Am J Med 2000; 109:378-385
    • (2000) Am J Med , vol.109 , pp. 378-385
    • Fine, M.J.1    Pratt, H.M.2    Obrosky, D.S.3
  • 9
    • 0032778289 scopus 로고    scopus 로고
    • Using healthcare claims data for outcomes research and pharmacoeconomic analyses
    • Birnbaum HG, Cremieux PY, Greenberg PE, et al. Using healthcare claims data for outcomes research and pharmacoeconomic analyses. Pharmacoeconomics 1999; 16:1-8
    • (1999) Pharmacoeconomics , vol.16 , pp. 1-8
    • Birnbaum, H.G.1    Cremieux, P.Y.2    Greenberg, P.E.3
  • 10
    • 0035842341 scopus 로고    scopus 로고
    • Economic burden of pneumonia in an employed population
    • Birnbaum HG, Morley M, Greenberg PE, et al. Economic burden of pneumonia in an employed population. Arch Intern Med 2001; 161:2725-2731
    • (2001) Arch Intern Med , vol.161 , pp. 2725-2731
    • Birnbaum, H.G.1    Morley, M.2    Greenberg, P.E.3
  • 11
    • 0036036433 scopus 로고    scopus 로고
    • Economic burden of respiratory infections in an employed population
    • Birnbaum HG, Morley M, Greenberg PE, et al. Economic burden of respiratory infections in an employed population. Chest 2002; 122:603-611
    • (2002) Chest , vol.122 , pp. 603-611
    • Birnbaum, H.G.1    Morley, M.2    Greenberg, P.E.3
  • 13
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3
  • 17
    • 0036735465 scopus 로고    scopus 로고
    • Pharmaceutical industry research and cost savings in community-acquired pneumonia
    • Kessler LA, Waterer GW, Barca R, et al. Pharmaceutical industry research and cost savings in community-acquired pneumonia. Am J Manag Care 2002; 8:798-800
    • (2002) Am J Manag Care , vol.8 , pp. 798-800
    • Kessler, L.A.1    Waterer, G.W.2    Barca, R.3
  • 18
    • 0037541094 scopus 로고    scopus 로고
    • Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia
    • Brown RB, Iannini P, Gross P, et al. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia. Chest 2003; 123:1503-1511
    • (2003) Chest , vol.123 , pp. 1503-1511
    • Brown, R.B.1    Iannini, P.2    Gross, P.3
  • 19
    • 0036430388 scopus 로고    scopus 로고
    • Cost-effectiveness of IV-to-oral switch therapy
    • Paladino JA, Gudgel LD, Forrest A, et al. Cost-effectiveness of IV-to-oral switch therapy. Chest 2002; 122:1271-1279
    • (2002) Chest , vol.122 , pp. 1271-1279
    • Paladino, J.A.1    Gudgel, L.D.2    Forrest, A.3
  • 20
    • 0031012761 scopus 로고    scopus 로고
    • A prediction rule to identify low-risk patients with community-acquired pneumonia
    • Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250
    • (1997) N Engl J Med , vol.336 , pp. 243-250
    • Fine, M.J.1    Auble, T.E.2    Yealy, D.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.